Andrew Neill is a highly accomplished Chief Financial Officer with a remarkable professional background. With over 3,000 LinkedIn connections, Neill has established a robust network of industry professionals. Currently serving as the CFO of Shattuck Labs, a clinical-stage biotechnology company based in Austin, Texas, Neill has been instrumental in pioneering the development of bi-functional fusion proteins as a groundbreaking class of biologic medicine for cancer and autoimmune disease treatment.

Before joining Shattuck Labs, Neill demonstrated exceptional leadership as the VP of Finance and Corporate Strategy for the same company. Prior to that, Neill served as Corporate and Business Development Officer at Lumos Pharma, a biotechnology company focused on developing therapeutics for x-linked mental retardation and Autism Spectrum Disorder. Notably, Neill worked on securing funding from the prestigious National Institutes of Health's Therapeutics for Rare and Neglected Diseases program.

Throughout their career, Neill has showcased expertise in market research and investments, making them a valuable asset in any professional setting. With a Master of Business Administration degree from The Wharton School, specializing in Health Care Management and Finance, Neill possesses the advanced knowledge and skills necessary for strategic decision-making. They also hold a Bachelor of Business Administration in Finance from Texas Christian University.

With their vast experience and proven track record, Andrew Neill is an exceptional CFO who continuously drives growth and success in the biotechnology industry.